| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/26/2007 | WO2007047405A1 Ddc compositions |
| 04/26/2007 | WO2007047401A2 A1 adenosine receptor agonists |
| 04/26/2007 | WO2007047394A2 Thiotriazolyl derivatives |
| 04/26/2007 | WO2007047351A2 Methods for treating hypertension in overweight and obese individuals |
| 04/26/2007 | WO2007047339A2 Methods of inhibiting poxvirus growth |
| 04/26/2007 | WO2007047327A2 Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency |
| 04/26/2007 | WO2007047323A2 Methods to treat alzheimer's disease or other disorders mediated by amyloid-beta accumulation in a subject |
| 04/26/2007 | WO2007047315A1 Amifostine dihydrate crystalline composition |
| 04/26/2007 | WO2007047305A1 Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors |
| 04/26/2007 | WO2007047282A1 Treatment of benign prostatic hypertrophy and lower urinary tract symptoms |
| 04/26/2007 | WO2007047253A2 Pharmaceutical formulations of cyclodextrins and antifungal azole compounds |
| 04/26/2007 | WO2007047207A2 5-lipoxygenase-activating protein (flap) inhibitors |
| 04/26/2007 | WO2007047202A1 Substituted heterocyclic compounds with cxcr3 antagonist activity |
| 04/26/2007 | WO2007047177A1 Acyl indoles, compositions containing such compounds and methods of use |
| 04/26/2007 | WO2007047040A2 Directly compressible extended release alprazolam formulation |
| 04/26/2007 | WO2007047010A2 Anti-emetic uses of cannabinoid analogs |
| 04/26/2007 | WO2007046966A2 Methods for the treatment of influenza |
| 04/26/2007 | WO2007046935A2 Compositions, systems, kits, and methods of administering rapamycin analogs with paclitaxel using medical devices |
| 04/26/2007 | WO2007046868A2 Thiazolidine derivatives and their uses as therapeutic agents |
| 04/26/2007 | WO2007046842A2 Composition for inhibition of cathepsin k |
| 04/26/2007 | WO2007046775A1 Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom |
| 04/26/2007 | WO2007046747A1 Novel bicyclic sulfonamides for use as glucocorticoid receptor modulators in the treatment of inflammatory diseases |
| 04/26/2007 | WO2007046729A1 Method of acting upon organism by targeted delivery of biologicaly active substances into m itochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose |
| 04/26/2007 | WO2007046721A2 A method of manufacturing 3-(4-hydroxyphenyl)propanoic acid amide, its application in the manufacture of anti-aging compositions and an anti-aging composition |
| 04/26/2007 | WO2007046698A1 Preventing diseases in infants delivered via caesarean section |
| 04/26/2007 | WO2007046697A1 Method for treating and/or preventing infections in infants delivered via caesarean section |
| 04/26/2007 | WO2007046554A1 Process for production of dibenzoxepinopyrrole compound, intermediate for production of the compound, and process for production of the intermediate |
| 04/26/2007 | WO2007046550A1 Pyrazole compounds having cannabinoid receptor (cb1) antagonizing activity |
| 04/26/2007 | WO2007046548A1 Pyrazolo[1,5-a]pyrimidine compounds as cannabinoid receptor antagonists |
| 04/26/2007 | WO2007046544A1 Preparation for external application comprising salt of mast cell degranulation inhibitor having carboxyl group with organic amine |
| 04/26/2007 | WO2007046524A1 EXTRACT LIQUID CONTAINING β-CRYPTOXANTHIN INGREDIENT, AND FOOD OR BEVERAGE AND SOAP OR COSMETIC EACH CONTAINING THE EXTRACT LIQUID |
| 04/26/2007 | WO2007046456A1 Agent for preventing or treating pancreas cancer, ovary cancer or liver cancer containing novel water-soluble prodrug |
| 04/26/2007 | WO2007046426A1 Atr inhibitor |
| 04/26/2007 | WO2007046411A1 Method for stabilization of isoxazole compound |
| 04/26/2007 | WO2007046392A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 04/26/2007 | WO2007046356A1 Carrier composition for nucleic acid transport |
| 04/26/2007 | WO2007046347A1 Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis |
| 04/26/2007 | WO2007046318A1 Liquid preparation for external application containing indomethacin |
| 04/26/2007 | WO2007046315A1 External preparation for skin |
| 04/26/2007 | WO2007046123A2 Composition containing vitamins k and d as well as taurine for the preventio and treatment of osteoporosis |
| 04/26/2007 | WO2007046122A2 Ozonised oil, process for the preparation and use thereof in medical field |
| 04/26/2007 | WO2007046112A1 Arylthioether tryptamine derivatives as functional 5-ht6 ligands |
| 04/26/2007 | WO2007046111A1 Carbazole derivatives as functional 5-ht6 ligands |
| 04/26/2007 | WO2007046101A2 Method and system for sharing content among mobile devices and purchasing online |
| 04/26/2007 | WO2007046087A2 Pharmaceutical compositions and diagnostic methods for inflammatory skin disesaes, disorders or conditions |
| 04/26/2007 | WO2007046083A2 Compositions for treatment of eye diseases |
| 04/26/2007 | WO2007046022A2 Inhibitors of phosphodiesterase type-iv |
| 04/26/2007 | WO2007046004A1 Treatment of the symptoms of bladder irritation |
| 04/26/2007 | WO2007046003A1 Treatment of stress urinary incontinence and mixed urinary incontinence |
| 04/26/2007 | WO2007045989A1 Pyridyl derivatives useful as h3 ligands |
| 04/26/2007 | WO2007045987A1 New anti-malaria derivatives of 4-aminoquinoline |
| 04/26/2007 | WO2007045982A2 Use of collagen in combination with oxygen- and ozonereleasing perfluorocarbons for the preparation of a medicament for the treatment of skin lesions |
| 04/26/2007 | WO2007045980A1 Compositions of phosphodiesterase type iv inhibitors |
| 04/26/2007 | WO2007045979A1 Pharmaceutical compositions of muscarinic receptor antagonists |
| 04/26/2007 | WO2007045959A2 Antioxidant and fe2+chelating properties of herbal extracts |
| 04/26/2007 | WO2007045911A1 Integral membrane protein |
| 04/26/2007 | WO2007045877A1 4-heteroarymethyl substituted phthalazinone derivatives |
| 04/26/2007 | WO2007045876A1 Chromenones and their use as modulators of metabotropic glutamate receptors |
| 04/26/2007 | WO2007045868A1 Pyrazoles useful in the treatment of inflammation |
| 04/26/2007 | WO2007045867A1 3 -aminoindole compounds as crth2 receptor ligands |
| 04/26/2007 | WO2007045861A1 Cinnoline compounds as inhibitors of phosphodiesterase type iv (pde4) |
| 04/26/2007 | WO2007045844A1 Benzamide compounds useful as histone deacetylase inhibitors |
| 04/26/2007 | WO2007045761A1 Amidine derivatives and their uses as medicine |
| 04/26/2007 | WO2007045758A1 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof |
| 04/26/2007 | WO2007045693A1 Novel unsaturated fatty hydroxy acid derivatives and the dermocosmetologic use thereof |
| 04/26/2007 | WO2007045672A1 Selected cgrp antagonists method for production and use thereof as medicament |
| 04/26/2007 | WO2007045639A1 Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients |
| 04/26/2007 | WO2007045622A1 Oxazolo [4 , 5-b] pyridine compounds as nitric oxide synthase inhibitors |
| 04/26/2007 | WO2007045620A1 Use of pramipexol for treating moderate to severe restless legs syndrome (rls) |
| 04/26/2007 | WO2007045593A2 Naphthyl derivatives as inhibitors of beta-amyloid aggregation |
| 04/26/2007 | WO2007045573A1 Phenyl-acetamide nnrt inhibitors |
| 04/26/2007 | WO2007045572A1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors |
| 04/26/2007 | WO2007045533A1 Dietary supplement energy-providing to skeletal muscles and protecting the cardio vascular tract |
| 04/26/2007 | WO2007045513A1 Method for preventive hormonal contraception on demand |
| 04/26/2007 | WO2007045478A1 Novel 1-aza bicycloalkyl derivatives for the treatment of psychotic and neurodegenerative disorders |
| 04/26/2007 | WO2007045462A2 Novel vanilloid receptor ligands and their use for producing medicaments |
| 04/26/2007 | WO2007045445A1 Dispersible tablets comprising deferasirox |
| 04/26/2007 | WO2007045433A1 Dicarboxylic acid derivatives and their use |
| 04/26/2007 | WO2007045393A1 Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases |
| 04/26/2007 | WO2007045392A1 Triazolopyridine derivatives as inhibitors of lipases and phospholipases |
| 04/26/2007 | WO2007045370A1 Tetrazol derivatives and their use for the treatment of cardiovascular diseases |
| 04/26/2007 | WO2007045369A1 Difluorophenol derivatives and their use |
| 04/26/2007 | WO2007045367A1 Cyclopropylacetic acid derivatives and use thereof |
| 04/26/2007 | WO2007045366A1 Heterocyclic compounds with carboxyl isostere groups and their use for the treatment of cardiovascular diseases |
| 04/26/2007 | WO2007045353A2 Combined preparation of o-acetylsalicylic acid salts |
| 04/26/2007 | WO2007045352A1 Transdermal therapeutic system for administering lipophilic and/or cutaneous low-permeable active substances |
| 04/26/2007 | WO2007045339A1 Imidazole derivatives as inhibitors of tafia |
| 04/26/2007 | WO2007045151A1 Compounds and their pharmaceutical compositions for the treatment of nasal cavum hypersecretion and chronic obstructive pulmonary disease |
| 04/26/2007 | WO2007045116A1 Treatment and prevention of benign pigmented moles (naevi) using artemisinine and the derivatives thereof |
| 04/26/2007 | WO2007045096A1 Oligoheteroaromatic luminiscent assemblies as high-affinity dna sequence-directed ligands |
| 04/26/2007 | WO2007045060A1 Pharmaceutical compositions containing erythrine mulungu derivatives and processes for their production |
| 04/26/2007 | WO2007045027A1 Reduction of side effects from aromatase inhibitors used for treating breast cancer |
| 04/26/2007 | WO2007045010A1 Inhibitory compounds |
| 04/26/2007 | WO2007045009A1 Microbicidal dendrimer composition delivery system |
| 04/26/2007 | WO2007031501A3 Pyridylsulfonamidyl-pyrimidines for the prevention of blood vessel graft failure |
| 04/26/2007 | WO2007028256A3 Polysaccharides compositions comprising fucans and galactans and their use to reduce extravasation and inflammation |
| 04/26/2007 | WO2007027941A3 Compositions and methods for preparation of poorly water soluble drugs with increased stability |
| 04/26/2007 | WO2007027819A3 Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents |
| 04/26/2007 | WO2007027477A3 Treating vulvodynia using prodrugs of gaba analogs |
| 04/26/2007 | WO2007027233A3 Derivatives of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid |